Consumer Staples Struggle, Coty Faces Challenges
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 17 2026
0mins
Source: Yahoo Finance
- Consumer Stock Performance: Over the past six months, consumer staples stocks have declined by 2.3%, contrasting with the S&P 500's 10% rise, indicating a diminishing defensive investment characteristic in volatile markets.
- Coty's Financial Struggles: With a market cap of $2.01 billion, Coty has shown no organic revenue growth over the past two years, and demand is expected to decline in the next 12 months, leading to a 29.3% annual drop in earnings per share, highlighting severe profitability issues.
- Colgate-Palmolive's Strength: Colgate-Palmolive, valued at $69.97 billion, boasts a revenue base of $20.8 billion and a gross margin of 60.4%, demonstrating strong customer loyalty and market influence, making it a stock worth watching.
- Philip Morris's Robust Performance: With a market cap of $291.3 billion, Philip Morris showcases a highly efficient business model with a gross margin of 66.5% and an operating margin of 36.5%, indicating strong cash flow capabilities that attract investor interest.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.230
Low
2.50
Averages
4.30
High
10.00
Current: 2.230
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Coty Inc. Shareholder Class Action Notice
- Shareholder Lawsuit Notice: The Gross Law Firm issues a notice to Coty Inc. shareholders, encouraging those who purchased shares between November 5, 2025, and February 4, 2026, to contact the firm for potential lead plaintiff appointment to partake in recovery.
- Performance Warning: Coty revealed in its Q2 FY 2026 financial results that its Consumer Beauty segment underperformed, leading to the withdrawal of its EBITDA guidance, reflecting slowing growth and compressed margins due to increased marketing investments.
- Significant Stock Decline: Coty's stock price plummeted from $3.43 per share on February 4, 2026, to $2.66 per share by February 6, 2026, marking a 22% decline, indicating strong market concerns regarding the company's performance and outlook.
- Management Change Impact: Alongside the disappointing results, Coty announced a CEO transition, highlighting issues of “operational discipline” within the company, which may further undermine investor confidence amid ongoing market challenges.
See More
Coty Shareholder Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, to apply as lead plaintiffs by May 22, 2026, or risk losing representation in the class action lawsuit.
- Fee Arrangement: Investors participating in the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages more affected shareholders to join the litigation.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which resulted in investor losses when the truth emerged, highlighting the company's vulnerabilities in market competition.
- Law Firm's Strength: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resource advantages in handling similar cases, prompting investors to carefully select experienced legal counsel.
See More
Coty Faces Expanded Securities Class Action Lawsuit
- Expanded Lawsuit Timeline: Hagens Berman has filed a new securities class action against Coty in the Southern District of New York, extending the recovery period to May 7, 2025, through February 4, 2026, thereby providing a broader opportunity for all investors who purchased Coty stock during this timeframe to seek compensation.
- Allegations of Concealed Performance: The lawsuit alleges that Coty failed to disclose significant underperformance in the consumer beauty market, aggressive profit margin compression due to unsustainable marketing investments, and a sharp deceleration in prestige fragrance growth during the expanded period, misleading investors about the company's true operational health.
- Stock Price Collapse Impact: Following the February 4, 2026 financial results announcement revealing over a 70% year-over-year drop in operating income for the consumer beauty segment and an 18% decline in prestige fragrance income, Coty's stock plummeted approximately 22% from $3.43 to $2.66 per share, erasing hundreds of millions in shareholder value.
- Investor Action Call: Hagens Berman urges Coty investors who suffered significant losses during the expanded period to submit their claims promptly and encourages witnesses with relevant information to contact the firm to assist in the investigation and potentially benefit from the SEC Whistleblower program.
See More
Multiple Companies Facing Class Action Lawsuits
- Atara Biotherapeutics Lawsuit: Atara is facing allegations during the class period from May 20, 2024, to January 9, 2026, for failing to disclose manufacturing issues that jeopardized FDA approval for tabelecleucel, potentially leading to significant negative impacts on its financial condition.
- Coty Performance Issues: Coty Inc. is accused during the period from May 7, 2025, to February 4, 2026, of not disclosing underperformance in its Consumer Beauty segment and compressed margins due to increased marketing investments, which misled investors about the company's prospects.
- Super Micro Compliance Violations: Super Micro Computer is facing allegations from February 2, 2024, to March 19, 2026, for selling servers to Chinese companies, violating U.S. export control laws, which could expose the company to regulatory scrutiny.
- ImmunityBio Capability Overstatement: ImmunityBio is accused during the class period from January 19, 2026, to March 24, 2026, of overstating Anktiva's capabilities, leading to materially misleading statements about the company's business and operations, affecting investor confidence.
See More
Faruqi & Faruqi Encourages Coty Investors to Reach Out
- Legal Action Reminder: Faruq & Faruqi LLP is investigating potential claims against Coty Inc., urging investors who purchased securities between November 5, 2025, and February 4, 2026, to be aware of possible legal risks.
- Investor Rights Protection: Partner Josh Wilson encourages affected investors to reach out directly to discuss their legal rights, demonstrating a commitment to safeguarding investor interests.
- Class Action Deadline: The firm reminds investors that May 22, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action against Coty, emphasizing the importance of timely action.
- Firm Background: Since its founding in 1995, Faruqi & Faruqi has recovered hundreds of millions of dollars for investors, showcasing its expertise and successful track record in securities law.
See More
Coty Faces Class Action Lawsuit Over Securities Violations
- Class Action Filed: Bronstein, Gewirtz & Grossman LLC has initiated a class action lawsuit against Coty Inc. and certain officers, alleging violations of federal securities laws on behalf of investors who acquired Coty securities between November 5, 2025, and February 4, 2026, seeking damages.
- False Statements Allegation: The complaint claims that throughout the class period, defendants made materially false and misleading statements regarding Coty's growth and profitability, failing to disclose underperformance in its Consumer Beauty segment and a slowdown in market growth.
- Margin Pressure: Coty's margins are reportedly under pressure due to increased marketing expenditures, which have contributed to a deceleration in growth within its Prestige fragrance segment, adversely affecting the company's overall business outlook.
- Investor Action Encouraged: Affected investors are urged to apply for lead plaintiff status by May 22, 2026, to participate in potential recovery, with the law firm stating that fees will only be charged upon successful recovery.
See More
Coty Inc. Shareholder Class Action Notice
- Shareholder Lawsuit Notice: The Gross Law Firm issues a notice to Coty Inc. shareholders, encouraging those who purchased shares between November 5, 2025, and February 4, 2026, to contact the firm for potential lead plaintiff appointment to partake in recovery.
- Performance Warning: Coty revealed in its Q2 FY 2026 financial results that its Consumer Beauty segment underperformed, leading to the withdrawal of its EBITDA guidance, reflecting slowing growth and compressed margins due to increased marketing investments.
- Significant Stock Decline: Coty's stock price plummeted from $3.43 per share on February 4, 2026, to $2.66 per share by February 6, 2026, marking a 22% decline, indicating strong market concerns regarding the company's performance and outlook.
- Management Change Impact: Alongside the disappointing results, Coty announced a CEO transition, highlighting issues of “operational discipline” within the company, which may further undermine investor confidence amid ongoing market challenges.
See More
Coty Shareholder Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, to apply as lead plaintiffs by May 22, 2026, or risk losing representation in the class action lawsuit.
- Fee Arrangement: Investors participating in the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages more affected shareholders to join the litigation.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which resulted in investor losses when the truth emerged, highlighting the company's vulnerabilities in market competition.
- Law Firm's Strength: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resource advantages in handling similar cases, prompting investors to carefully select experienced legal counsel.
See More
Coty Faces Expanded Securities Class Action Lawsuit
- Expanded Lawsuit Timeline: Hagens Berman has filed a new securities class action against Coty in the Southern District of New York, extending the recovery period to May 7, 2025, through February 4, 2026, thereby providing a broader opportunity for all investors who purchased Coty stock during this timeframe to seek compensation.
- Allegations of Concealed Performance: The lawsuit alleges that Coty failed to disclose significant underperformance in the consumer beauty market, aggressive profit margin compression due to unsustainable marketing investments, and a sharp deceleration in prestige fragrance growth during the expanded period, misleading investors about the company's true operational health.
- Stock Price Collapse Impact: Following the February 4, 2026 financial results announcement revealing over a 70% year-over-year drop in operating income for the consumer beauty segment and an 18% decline in prestige fragrance income, Coty's stock plummeted approximately 22% from $3.43 to $2.66 per share, erasing hundreds of millions in shareholder value.
- Investor Action Call: Hagens Berman urges Coty investors who suffered significant losses during the expanded period to submit their claims promptly and encourages witnesses with relevant information to contact the firm to assist in the investigation and potentially benefit from the SEC Whistleblower program.
See More
Multiple Companies Facing Class Action Lawsuits
- Atara Biotherapeutics Lawsuit: Atara is facing allegations during the class period from May 20, 2024, to January 9, 2026, for failing to disclose manufacturing issues that jeopardized FDA approval for tabelecleucel, potentially leading to significant negative impacts on its financial condition.
- Coty Performance Issues: Coty Inc. is accused during the period from May 7, 2025, to February 4, 2026, of not disclosing underperformance in its Consumer Beauty segment and compressed margins due to increased marketing investments, which misled investors about the company's prospects.
- Super Micro Compliance Violations: Super Micro Computer is facing allegations from February 2, 2024, to March 19, 2026, for selling servers to Chinese companies, violating U.S. export control laws, which could expose the company to regulatory scrutiny.
- ImmunityBio Capability Overstatement: ImmunityBio is accused during the class period from January 19, 2026, to March 24, 2026, of overstating Anktiva's capabilities, leading to materially misleading statements about the company's business and operations, affecting investor confidence.
See More
Faruqi & Faruqi Encourages Coty Investors to Reach Out
- Legal Action Reminder: Faruq & Faruqi LLP is investigating potential claims against Coty Inc., urging investors who purchased securities between November 5, 2025, and February 4, 2026, to be aware of possible legal risks.
- Investor Rights Protection: Partner Josh Wilson encourages affected investors to reach out directly to discuss their legal rights, demonstrating a commitment to safeguarding investor interests.
- Class Action Deadline: The firm reminds investors that May 22, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action against Coty, emphasizing the importance of timely action.
- Firm Background: Since its founding in 1995, Faruqi & Faruqi has recovered hundreds of millions of dollars for investors, showcasing its expertise and successful track record in securities law.
See More
Coty Faces Class Action Lawsuit Over Securities Violations
- Class Action Filed: Bronstein, Gewirtz & Grossman LLC has initiated a class action lawsuit against Coty Inc. and certain officers, alleging violations of federal securities laws on behalf of investors who acquired Coty securities between November 5, 2025, and February 4, 2026, seeking damages.
- False Statements Allegation: The complaint claims that throughout the class period, defendants made materially false and misleading statements regarding Coty's growth and profitability, failing to disclose underperformance in its Consumer Beauty segment and a slowdown in market growth.
- Margin Pressure: Coty's margins are reportedly under pressure due to increased marketing expenditures, which have contributed to a deceleration in growth within its Prestige fragrance segment, adversely affecting the company's overall business outlook.
- Investor Action Encouraged: Affected investors are urged to apply for lead plaintiff status by May 22, 2026, to participate in potential recovery, with the law firm stating that fees will only be charged upon successful recovery.
See More
